Your browser doesn't support javascript.
loading
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.
Sun, Si; Li, Entao; Zhao, Gan; Tang, Jie; Zuo, Qianfei; Cai, Larry; Xu, Chuanfei; Sui, Cheng; Ou, Yangxue; Liu, Chang; Li, Haibo; Ding, Yuan; Li, Chao; Lu, Dongshui; Zhang, Weijun; Luo, Ping; Cheng, Ping; Gao, Yuwei; Tu, Changchun; Pitard, Bruno; Rosenecker, Joseph; Wang, Bin; Liu, Yan; Zou, Quanming; Guan, Shan.
Afiliación
  • Sun S; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Li E; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • Zhao G; Advaccine (Suzhou) Biopharmaceuticals Co., Ltd, Suzhou, China.
  • Tang J; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
  • Zuo Q; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Cai L; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
  • Xu C; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Sui C; Advaccine (Suzhou) Biopharmaceuticals Co., Ltd, Suzhou, China.
  • Ou Y; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Liu C; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Li H; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Ding Y; Advaccine (Suzhou) Biopharmaceuticals Co., Ltd, Suzhou, China.
  • Li C; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Lu D; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Zhang W; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Luo P; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Cheng P; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China.
  • Gao Y; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • Tu C; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • Pitard B; Immunology and New Concepts in ImmunoTherapy, INSERM, CNRS, Nantes Université, Univ Angers, Nantes, France.
  • Rosenecker J; Department of Pediatrics, Ludwig-Maximilians University of Munich, Munich, Germany.
  • Wang B; Advaccine (Suzhou) Biopharmaceuticals Co., Ltd, Suzhou, China; Key Laboratory of Medical Molecular Virology of MOH and MOE and Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Liu Y; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China. Electronic address: liu820512@163.com.
  • Zou Q; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China. Electronic address: qmzou2007@163.com.
  • Guan S; National Engineering Research Center of Immunological Products, Third Military Medical University, Chongqing, China. Electronic address: guanshan87@163.com.
Biomaterials ; 292: 121907, 2023 01.
Article en En | MEDLINE | ID: mdl-36436305

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas de ADN / Nanopartículas / COVID-19 Límite: Animals Idioma: En Revista: Biomaterials Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas de ADN / Nanopartículas / COVID-19 Límite: Animals Idioma: En Revista: Biomaterials Año: 2023 Tipo del documento: Article País de afiliación: China